SC 13G
SC 13G Filing
- Company
- HALOZYME THERAPEUTICS, INC.
- Filed
- March 19, 2004
- Accession Number
- 0000898432-04-000284
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →